AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, announced the launch of new, longer AngioSculpt PTA Scoring Balloon Catheters for the ...

FREMONT, Calif.-- AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the completion of enrollment in the Drug-Coated ...

January 6, 2011 — AngioSculpt percutaneous transluminal angioplasty (PTA) scoring balloon catheters, manufactured by AngioScore Inc, are subject to a class I US Food and Drug Administration (FDA) ...

FREMONT, Calif.--(BUSINESS WIRE)--AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced that the FDA has approved a ...

Sept. 16, 2005 — The U.S. Food and Drug Administration (FDA) has approved a Papanicolaou test for the detection of endocervical and endometrial glandular lesions; a scoring balloon catheter for the ...

Please provide your email address to receive an email when new articles are posted on . Spectranetics recently announced that it has received FDA 510(k) clearance for a scoring balloon catheter in ...

When a device meets its primary endpoint in a first-in-human clinical trial, it's generally regarded as a good thing. But when a device performs even better than expected, it's very good. And when the ...

FREMONT, Calif.--(BUSINESS WIRE)--AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the successful initiation of ...

FREMONT, Calif.--(BUSINESS WIRE)--AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the successful initiation of ...